Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co
NYSE:BMY
Price:
43.99 USD
0.66%
Market Closed
Updated:
May 4, 2024
Bristol-Myers Squibb Co
Gross Profit
|
Bristol-Myers Squibb Co
Gross Profit Peer Comparison
Comparables:
JNJ
PFE
MRK
ZTS
LLY
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Gross Profit
$34.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
16%
|
CAGR 10-Years
11%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Gross Profit
$59.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
|
Pfizer Inc
NYSE:PFE
|
Gross Profit
$38.8B
|
CAGR 3-Years
55%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-1%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Gross Profit
$46.4B
|
CAGR 3-Years
18%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
|
|
Zoetis Inc
NYSE:ZTS
|
Gross Profit
$6B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Gross Profit
$28.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
See Also
What is Bristol-Myers Squibb Co's Gross Profit?
Gross Profit
34.6B
USD
34.6B
USD
Based on the financial report for Mar 31, 2024, Bristol-Myers Squibb Co's Gross Profit amounts to 34.6B USD.
What is Bristol-Myers Squibb Co's Gross Profit growth rate?
Gross Profit CAGR 10Y
11%
11%
Over the last year, the Gross Profit growth was -3%. The average annual Gross Profit growth rates for Bristol-Myers Squibb Co have been 2% over the past three years , 16% over the past five years , and 11% over the past ten years .
You don't have any saved screeners yet
